Neil D Christensen Selected Research

Viral DNA

1/2021	The environmental pollutant and tobacco smoke constituent dibenzo[def,p]chrysene is a co-factor for malignant progression of mouse oral papillomavirus infections.
1/2021	Mouse Papillomavirus L1 and L2 Are Dispensable for Viral Infection and Persistence at Both Cutaneous and Mucosal Tissues.
1/2019	Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models.
12/2015	Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.
2/2008	Protective immunity with an E1 multivalent epitope DNA vaccine against cottontail rabbit papillomavirus (CRPV) infection in an HLA-A2.1 transgenic rabbit model.
2/2007	Impact of genetic changes to the CRPV genome and their application to the study of pathogenesis in vivo.
1/2006	Protective cell-mediated immunity by DNA vaccination against Papillomavirus L1 capsid protein in the Cottontail Rabbit Papillomavirus model.
2/2004	The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neil D Christensen Research Topics

Disease

31	Infections 01/2022 - 10/2002
19	Neoplasms (Cancer) 01/2022 - 01/2002
19	Papilloma (Papillomatosis) 01/2021 - 07/2002
15	Papillomavirus Infections 01/2022 - 02/2005
6	Virus Diseases (Viral Diseases) 01/2022 - 12/2002
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2007 - 04/2002
2	Condylomata Acuminata (Genital Wart) 01/2022 - 12/2007
2	Hyperplasia 01/2021 - 04/2005
2	Brain Neoplasms (Brain Tumor) 03/2015 - 09/2002
2	Spontaneous Remission 04/2013 - 12/2002
2	Astrocytoma (Pilocytic Astrocytoma) 10/2008 - 09/2002
2	Glioma (Gliomas) 10/2008 - 09/2002
2	Hypersensitivity (Allergy) 03/2004 - 07/2002
1	Disease Progression 01/2022
1	Herpes Simplex 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Coronavirus Infections 01/2021
1	Epstein-Barr Virus Infections 10/2020
1	Progressive Multifocal Leukoencephalopathy 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Warts (Wart) 01/2018
1	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 03/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2014
1	Coinfection 08/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2013
1	Corneal Diseases (Corneal Disease) 03/2010
1	Epidermodysplasia Verruciformis 12/2007
1	Verrucous Carcinoma 04/2005
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 04/2005
1	Bone Resorption 01/2004
1	Breast Neoplasms (Breast Cancer) 01/2004
1	Neoplasm Metastasis (Metastasis) 01/2004

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 01/2022 - 02/2005
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2002
9	EpitopesIBA 12/2015 - 06/2006
9	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 04/2002
8	Viral DNAIBA 01/2021 - 02/2004
6	Peptides (Polypeptides)IBA 01/2014 - 07/2002
5	Neutralizing AntibodiesIBA 11/2020 - 10/2002
4	AntibodiesIBA 01/2021 - 04/2002
4	AntigensIBA 03/2015 - 01/2002
4	Amino Acids FDA Link 01/2007 - 12/2002
3	Antiviral Agents (Antivirals)IBA 01/2018 - 01/2005
3	Heparin (Liquaemin)FDA LinkGeneric 01/2017 - 12/2003
3	Monoclonal AntibodiesIBA 12/2007 - 08/2003
3	Immunoglobulin G (IgG)IBA 12/2007 - 04/2002
3	Capsid Proteins (Capsid Protein)IBA 10/2007 - 10/2005
2	Viral ProteinsIBA 01/2021 - 09/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	Papillomavirus Vaccines (HPV Vaccines)IBA 11/2020 - 02/2005
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2020 - 01/2005
2	Indicators and Reagents (Reagents)IBA 01/2017 - 08/2014
2	Codon (Codons)IBA 04/2013 - 08/2008
2	ImmunosorbentsIBA 04/2005 - 04/2002
2	EnzymesIBA 04/2005 - 04/2002
1	Contraceptive Agents (Contraceptives)IBA 01/2022
1	N,N-dimethyl-4-anisidine (DMPA)IBA 01/2022
1	MedroxyprogesteroneIBA 01/2022
1	DEPOIBA 01/2022
1	dibenzo(a,l)pyreneIBA 01/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021
1	SmokeIBA 01/2021
1	CarcinogensIBA 01/2021
1	Biological ProductsIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2018
1	molibresibIBA 01/2018
1	asoxime chloride (H16)IBA 12/2015
1	Tumor Viral Antigens (Large T Antigen)IBA 03/2015
1	Cidofovir (Vistide)FDA Link 08/2014
1	NucleosidesIBA 08/2014
1	Insulin (Novolin)FDA Link 06/2014
1	MicroRNAs (MicroRNA)IBA 06/2014
1	Protein Subunit VaccinesIBA 01/2014
1	Myelin Proteolipid ProteinIBA 02/2013
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2011
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 03/2010
1	HLA-A*02:01 antigenIBA 03/2010
1	GS-9191IBA 07/2009
1	Interleukin-13 Receptor alpha2 SubunitIBA 10/2008
1	A-Form DNA (A-DNA)IBA 10/2008
1	DNA VaccinesIBA 02/2008
1	Immunoglobulin M (IgM)IBA 12/2007
1	Immunoglobulin A (IgA)IBA 12/2007
1	Viral RNAIBA 03/2007
1	Integrin alpha6IBA 09/2006
1	Coloring Agents (Dyes)IBA 10/2005
1	CytokinesIBA 10/2005
1	Synthetic Vaccines (Recombinant Vaccines)IBA 02/2005
1	Pharmaceutical PreparationsIBA 01/2005
1	AgarIBA 07/2004
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2004
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2004
1	enhanced green fluorescent proteinIBA 01/2004
1	Integrin beta3 (GPIIIa)IBA 01/2004
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 12/2003

Therapy/Procedure

1	Immunomodulation 01/2020
1	Therapeutics 01/2015
1	Drug Therapy (Chemotherapy) 10/2008
1	Injections 01/2004